Ultra-low Temperature Freezer Market Size, Share, and Growth Forecast from 2025 - 2032

Ultra-low Temperature Freezer Market Size and Share Analysis

The global ultra-low temperature freezer market is anticipated to reach a size of US$ 0.8 Bn by 2025. It is set to experience a CAGR of 5.1% during the forecast period to reach a value of US$ 1.1 Bn by 2032.

Energy efficiency is becoming a priority in the industry owing to rising electricity costs and stringent environmental regulations. By 2032, energy-efficient Ultra-Low Temperature (ULT) freezers are set to account for 60% of the market. New models are predicted to decrease energy consumption by 30% to 50% compared to older freezers.

Biopharmaceutical industry continues to be a prominent driver of ULT freezer adoption, with applications in storing mRNA vaccines, cell therapies, and biologics. Increasing research in personalized medicine and genomics is driving the need for reliable ULT freezers for sample storage in biobanking.

Key Highlights of the Industry

• Food and beverage industry is increasingly using ULT freezers to preserve high-value and specialty foods, ensuring quality and safety.
• Integration of IoT technologies for real-time monitoring and remote management is becoming a key trend in the industry.
• Regulatory restrictions on hydrofluorocarbons (HFCs) are accelerating the adoption of sustainable refrigerants like hydrocarbons and CO2-based systems.
• By 2032, most new ULT freezers are likely to feature low-GWP refrigerants, meeting environmental compliance standards.
• Hybrid refrigeration systems that combine the benefits of both compressor-based and cryogenic (liquid nitrogen) systems are likely to witness growth in specialized applications such as biobanking and pharmaceutical storage.
• Sustainability is set to be a key driver, with manufacturers focusing on developing energy-efficient, eco-friendly models that meet the evolving regulatory requirements.
• By type, the upright freezers segment generated a share of 62.4% in 2024 owing to optimized space.
• Based on end user, the biobanks and blood banks segment held a share of 44.2% in 2024 as government authorities across the globe invested in biobanking infrastructure.
• North America ultra-low temperature freezer market is set to exhibit a CAGR of 5.3% through 2032 owing to well-established networks in the region.

Market Attributes	Key Insights
Ultra-low Temperature Freezer Market Size (2025E)	US$ 0.8 Bn
Projected Market Value (2032F)	US$ 1.1 Bn
Global Market Growth Rate (CAGR 2025 to 2032)	5.1%
Historical Market Growth Rate (CAGR 2019 to 2023)	4.4%

Presence of Leading Biopharmaceutical Companies in North America Bolsters Growth

The ultra-low temperature freezer market in North America held a share of 40.2% in 2024. The region, especially the U.S. is home to the largest biopharmaceutical companies, including Pfizer, Moderna, and Johnson and Johnson. These companies heavily rely on ULT freezers for the storage of temperature-sensitive biologics, vaccines, and gene therapies. For instance,

• The adoption rate of energy-efficient ULT freezers is set to increase significantly, with over 75% of new installations by 2030 featuring eco-friendly and energy-efficient technologies.

North America has a well-established network of hospitals, research laboratories, and academic institutions conducting cutting-edge research in genomics, regenerative medicine, and personalized medicine. Increased adoption of ULT freezers in these facilities supports long-term storage of biological samples, DNA, and cell lines.

The region is registered to host a number of biobanks for storing biological specimens, driven by developments in genomics and personalized medicine. The region's extensive cold chain infrastructure supports the distribution of vaccines and other biologics. During the pandemic, demand for ULT freezers in North America increased by 45%, significantly boosting sales for key manufacturers.

Upright Freezers are Preferred Due to their Enhanced Organization and Accessibility

Uptight freezers held a share of 62.4% in 2024. These offer vertical storage, making them ideal for facilities with limited floor space, enabling better organization and accessibility of samples without compromising storage capacity. Laboratories and research facilities with high sample throughput prefer upright freezers to optimize space.

Upright freezers typically provide larger storage capacities compared to chest freezers, accommodating a greater number of samples while maintaining a compact footprint. These models account for 60% of the total storage volume used in commercial and research laboratories. Around 75% of laboratory managers cite ease of access as a critical factor when choosing ULT freezers.

Innovations in insulation technology and compressor systems have made modern upright ULT freezers highly energy-efficient, addressing a traditional disadvantage. Energy-efficient upright freezers now consume up to 30% less energy than older models, making these cost-effective and environmentally friendly.

Rapid Establishment of Biobanks to Augment Demand Worldwide

Biobanks and blood banks accounted for a share of 44.2% in 2024. Blood banks are critical for storing blood, plasma, and related components used in transfusions and treatments. These require precise temperature control to maintain their usability over extended periods.

Regenerative medicine is dependent on the preservation of stem cells and other biological materials, which require ultra-low temperature storage to maintain their viability and efficacy. The COVID-19 pandemic underscored the importance of ULT freezers for vaccine storage.

Governments and private entities are investing heavily in biobanking infrastructure to support research and healthcare development. The U.S. government, in 2023, allocated over US$ 1.5 Bn for biobanking projects. The establishment of global biobank networks has increased the need for standardized and scalable storage solutions, further driving demand for ULT freezers. The global number of biobanks is estimated to increase to 1,500 by 2030.

Ultra-low Temperature Freezer Market Introduction and Trend Analysis

Potential growth in the global ultra-low temperature freezer industry is predicted to be driven by increased adoption of smart technologies for real time monitoring and data analysis. The industry is estimated to witness rising adoption of natural products with low Global Warming Potential (GWP).

Continuous growth in biobanking, personalized medicine, and regenerative medicine is predicted to drive future demand. Expansion of the cold chain logistics industry is likely to support global trade in frozen foods and pharmaceuticals. The development of vaccines and biologics for emerging diseases is likely to drive growth.

Historical Growth and Course Ahead

The ultra-low temperature freezer market growth was decent at a CAGR of 4.4% during the historical period from 2019 to 2023. The global COVID-19 pandemic created unprecedented demand for ULT freezers, particularly for storing mRNA-based COVID-19 vaccines like Pfizer-BioNTech and Moderna, which required storage at -70°C and -20°C, respectively. The global demand for ULT freezers surged by 40% in 2020, with manufacturers like Thermo Fisher Scientific and Eppendorf reporting record sales.

Growth of biopharmaceutical research and increasing adoption of regenerative medicine boosted demand for ULT freezers. Rise of biobanks for storing biological samples such as blood, tissues, and DNA contributed significantly to the market. Manufacturers introduced energy-efficient and eco-friendly ULT freezers to meet environmental regulations and reduce operational costs, enhancing their appeal across industries.

The forecast period is estimated to focus on energy-efficient and sustainable technologies to address environmental concerns and decrease operational costs. It is also likely to witness the development of freezers with lower energy consumption, thereby decreasing operational costs by 40% to 50% compared to older models.

Market Growth Drivers

High Adoption of Energy-efficient and Sustainable Technologies to Fuel Demand

ULT freezers consume significant energy, with a typical unit using around 16 to 20 kWh per day, equivalent to the energy consumption of a small household. Energy-efficient models help laboratories reduce operating costs.

• Laboratories account for 60% of the total energy use in research buildings, making energy-efficient equipment crucial for reducing total energy consumption. Several conventional ULT freezers use hydrofluorocarbons (HFCs), which have a high Global Warming Potential (GWP).

The Kigali Amendment to the Montreal Protocol (2016) mandates a phasedown of HFCs by 80% to 85% by 2047, encouraging the shift to natural refrigerants like hydrocarbons (HCs) and Carbon Dioxide (CO2). Manufacturers are progressively incorporating technologies like Vacuum Insulation Panels (VIPs), low-emissivity coatings, and variable-speed compressors to improve energy efficiency. Unique ULT freezers now consume 40% to 60% less energy compared to older models. For instance,

• Energy-efficient ULT freezers from market leaders like Thermo Fisher Scientific and PHCbi have energy ratings as low as 8 to 10 kWh per day.

Increasing Demand in the Food and Beverage Industry to Spur Sales

The frozen food sector is witnessing exponential growth owing to consumer preferences for convenience and long shelf-life products. ULT freezers are being used for storing premium frozen foods, including seafood, meat, and ready-to-eat meals, which require precise temperature controls to maintain quality. High-value and specialty foods, like truffles, caviar, and exotic fruits, usually require storage at ultra-low temperatures to preserve freshness and texture.

Rising consumer demand for such luxury items is driving demand for novel storage solutions. ULT freezers are becoming an integral part of the global cold chain logistics infrastructure, particularly in niche applications like frozen organic foods and plant-based alternatives. Stringent regulations on food safety and hygiene, like the FDA Food Safety Modernization Act (FSMA) in the U.S., necessitates the use of unique storage technologies.

ULT freezers assist in ensuring compliance by maintaining consistent temperatures and preventing microbial contamination. Food manufacturers and research facilities increasingly use ULT freezers to store ingredients and samples for quality testing, shelf-life studies, and product development. This supports the creation of new food products that cater to evolving consumer preferences.

The global ice cream market is experiencing significant growth, driven by rising consumer interest in artisanal and premium frozen desserts. ULT freezers are essential for maintaining the quality of frozen desserts during production and storage.

Market Restraining Factors

High Initial Investment to Create Hindrances in the Market

High upfront cost of Ultra-Low Temperature (ULT) freezers is a significant barrier to adoption, particularly for small-scale laboratories, academic institutions, and facilities in emerging markets. Novel ULT freezers with features like IoT-enabled monitoring, energy efficiency, and eco-friendly refrigerants typically cost between US$ 10,000 and US$ 25,000 per unit. Basic models are less costly but may lack essential features like optimized energy consumption or stable ultra-low temperature performance.

ULT freezers require specialized infrastructure, including reinforced floors, adequate ventilation, and reliable electrical systems. In some cases, laboratories may be required to upgrade their facilities, incurring additional costs ranging from US$ 5,000 to US$ 20,000 depending on the scale of modifications. Several facilities invest in backup power systems and redundant freezers to prevent sample loss due to power outages and freezer failure.

Backup systems can add an additional 15% to 20% to the total investment, significantly increasing the financial burden on organizations. Regular maintenance and calibration are critical to ensure consistent performance of ULT freezers. Maintenance contracts typically cost between US$ 1,000 and US$ 2,500 annually per freezer, further adding to the total cost of ownership.

Market Growth Opportunities

Surging Requirement in Biopharmaceutical and Vaccine Storage Creates Prospects

During the COVID-19 pandemic, vaccines like the Pfizer-BioNTech required storage at ultralow temperatures, leading to a surging demand for ULT freezers. For example,

• According to the World Health Organization (WHO), around 13 billion COVID-19 vaccine doses were administered globally by 2024, with many requiring specialized cold storages.

New vaccines for diseases like influenzas, RSV, and emerging pathogens are estimated to require ULT storage solutions. Biopharmaceuticals, including monoclonal antibodies, biosimilars, and cell/gene therapies, are temperature-sensitive and require ULT storage to maintain efficacy. Organizations like UNICEF and Gavi, the Vaccine Alliance are investing heavily in ULT storage for immunization programs, especially in low- and middle-income countries.

Emergence of Several Biobanks Globally to Create New Opportunities

Growth in biobanking is creating substantial demand for ULT freezers to preserve biological specimens. Precision medicine heavily relies on large-scale biobanking for storing biological specimens such as blood, DNA, RNA, tissues, and cells. Establishment of public and private biobanks is accelerating, fueled by developments in genomics, proteomics, and personalized medicine. For example,

• By 2025, the number of biobanks worldwide is estimated to exceed 2,000 facilities, thereby increasing the demand for ULT storage solutions.

In oncology, biobanks store tumor samples for research into genetic mutations and drug development.

• Rise in global cancer cases projected at 29.5 million by 2040, as per the WHO necessitates long-term storage of biospecimens for research.

Innovations in cryopreservation methods enhance the ability of biobanks to store samples at ULT conditions for decades. Governments and private entities are funding biobank initiatives to support translational research. For instance,

• The U.K. Biobank stores samples from over 500,000 participants, supporting various health studies. The Million Veteran Program (MVP) in the U.S. collects samples from over 1 million veterans for genetic and health research.

Competitive Landscape for the Ultra-low Temperature Freezer Market

Companies in the ultra-low temperature freezer market are developing freezers with unique features like energy efficiency, eco-friendly refrigerants, and improved temperature uniformity. They are working on introducing ultra-low noise or compact models tailored for laboratories and research facilities having limited space.

Businesses are also transitioning to green refrigerants and energy-efficient designs to meet global environmental standards. They are highlighting decreased carbon footprints and compliance with energy certifications as the key selling points of their products.

Brands are further collaborating with pharmaceutical companies, research institutions, and government agencies to secure bulk orders. They are increasingly partnering with logistics and storage companies to offer end-to-end solutions for temperature-sensitive items.

Recent Industry Developments

• In April 2024, Thermo Fisher Scientific Inc., introduced TSX Universal Series ULT Freezers to acclimate to scientists’ workflows across multiple lab settings.
• In February 2024, Lauda announced the launch of the first ever mobile ultra-low temperature freezer using R290 band R170.
• In February 2023, PHC Corporation launched the PHCbibrand VIP ECO SMART ultra-low temperature freezer series for use in facilities, including medical institutions, universities, and pharmaceutical companies.
• In March 2023, BioLife Solutions, Inc., officially announced the launch of Ultraguard, the first -70°C phase change material created specifically for ultralow temperature protection.

Ultra-low Temperature Freezer Market Report Scope

Attributes	Detail
Forecast Period	2025 to 2032
Historical Data Available for	2019 to 2023
Market Analysis	US$ Billion for Value
Key Regions Covered	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Key Market Segments Covered	Type Temperature Range Capacity End User Region
Key Companies Profiled in the Report	Thermo Fisher Scientific Inc. PHC Holdings Corporation Eppendorf AG Esco Micro Pte Ltd. Helmer Scientific Arctiko A/S Bionics Scientific Technologies (P) Ltd Glen Dimplex Haier Biomedical LABCOLD BINDER GmbH BioLife Solutions
Report Coverage	Market Forecast and Trends Company Share Analysis Competitive Intelligence DROT Analysis Market Dynamics and Challenges Strategic Growth Initiatives
Customization and Pricing	Available upon request

Market Segmentation

By Type

• Upright Freezers
• Chest Freezers

By Temperature Range

• -40°C to -86°C
• -87°C to -150°C

By Capacity

• Less than 100 Liters
• 101 to 300 Liters
• 301 to 500 Liters
• More than 500 Liters

By End User

• Academic and Research Institutes
• Biobanks and Blood Banks
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Centers
• Other End Users (e.g., Forensic Laboratories)

By Region

• North America
• Latin America
• Europe
• East Asia
• South Asia and Oceania
• Middle East and Africa

To know more about delivery timeline for this report Contact Sales